News of Note—Sanofi's Dengvaxia, HPV vaccine and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week.

> Dengvaxia's safety scandal in the Philippines lowered confidence in vaccines overall in the country. Release

> A study found that teenage girls are not more likely to engage in risky sexual behavior if they receive the HPV vaccine. Newsweek article

> Inovio Pharmaceuticals' Ebola vaccine candidate elicited immune responses in a preclinical study. Release

> The Walter Reed Army Institute of Research kicked off an early stage trial of a vaccine candidate against Marburg virus. Release

> Valneva advanced its Chikungunya vaccine candidate to the next stage within a phase 1 trial program. Release

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.